Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.
Status:
Not yet recruiting
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
Locally advanced cervical cancer (stage IB3, IIA2) patients with postoperative risk factors
need better treatment. We initiated a clinical study to explore the effectiveness of adjuvant
chemoradiotherapy followed by Zimberelimab for these patients.
Phase:
Phase 2
Details
Lead Sponsor:
Obstetrics & Gynecology Hospital of Fudan University